Related Experiment Video
Updated: Feb 7, 2026

An Optimized Method for Isolating and Expanding Invariant Natural Killer T Cells from Mouse Spleen
Published on: October 29, 2015
Utilization of invariant natural killer T cells for gastric cancer treatment
Qi Xu1, Jingjing Li1, Na Zhang2
1Department of Abdominal Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, PR China.
Aim:
To evaluate the expression of CD1d and the susceptibility to invariant natural killer T (iNKT) cells in gastric cancer.
Methods:
The expression of CD1d was examined in gastric cancer. The in vitro and in vivo cytotoxic activities of iNKT cells were evaluated against gastric cancer cell lines.
Results:
CD1d was expressed in gastric cancer cell lines and primary tumors. iNKT cells have potent in vivo and in vitro anti-tumor activities against CD1d-positve gastric cancer in the presence of α-galactosylceramide. Cisplatin could upregulate CD1d expression in gastric cancer cells and make them more vulnerable to iNKT cell-mediated cytotoxicity.
Conclusion:
These results justified clinical translation of this iNKT cell-based therapeutics, either used alone or combined with chemotherapy, for the treatment of patients with gastric cancer.
Insights
Invariant natural killer T (iNKT) cells show potent anti-tumor activity against gastric cancer expressing CD1d. Chemotherapy can enhance this susceptibility, supporting iNKT cell therapy for gastric cancer.
Area of Science:
- Immunology
- Oncology
- Cancer Therapy
Background:
- Gastric cancer remains a significant global health challenge.
- Understanding immune cell interactions is crucial for developing novel therapies.
Purpose of the Study:
- To investigate the expression of CD1d in gastric cancer.
- To assess the efficacy of invariant natural killer T (iNKT) cells against gastric cancer.
Main Methods:
- Examined CD1d expression in gastric cancer cell lines and primary tumors.
- Evaluated the in vitro and in vivo cytotoxic effects of iNKT cells on gastric cancer cells.
Main Results:
- CD1d expression was confirmed in gastric cancer.
- iNKT cells demonstrated significant anti-tumor activity against CD1d-positive gastric cancer.
- Cisplatin treatment upregulated CD1d expression, increasing gastric cancer cell vulnerability to iNKT cells.
Conclusions:
- iNKT cell-based therapy holds promise for gastric cancer treatment.
- Combination therapy with chemotherapy may enhance treatment outcomes.
- These findings support the clinical translation of iNKT cell therapy for gastric cancer.
Related Concept Videos
Treatment Resistant Cancers
Nature and Nurture
Linear time-invariant Systems
The input-output behavior of an LTI system can be fully defined by its response to an impulsive excitation at its input. Once this impulse response is known, the system's reaction to any other input can be...
What is Natural Selection?
Gastric Emptying
Gastric Motility
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...

